As of 2025-10-22, the EV/EBITDA ratio of Rapid Dose Therapeutics Corp (DOSE.CN) is -6.42. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DOSE.CN's latest enterprise value is 21.26 mil CAD. DOSE.CN's TTM EBITDA according to its financial statements is -3.31 mil CAD. Dividing these 2 quantities gives us the above DOSE.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 1.1x - 1.7x | 1.4x |
| Forward P/E multiples | 1.4x - 2.2x | 1.8x |
| Fair Price | (0.04) - (0.04) | (0.04) |
| Upside | -122.4% - -126.2% | -124.9% |
| Date | EV/EBITDA |